Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 123, Issue 1, 2005, Pages 87-91

  Arvidsson, Caroline ^a   Hellborg, Margareta ^a   Gemzell Danielsson, Kristina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acceptability; Medical abortion; Misoprostol; Oral; Vaginal

Indexed keywords

ANTIEMETIC AGENT; BENZODIAZEPINE DERIVATIVE; CODEINE; DIAZEPAM; DICLOFENAC; HEXOBARBITAL; METOCLOPRAMIDE; MIFEPRISTONE; MISOPROSTOL; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PANOCOD; PARACETAMOL; THIETHYLPERAZINE; THIETHYLPERAZINE MALEATE;

ABORTION; AMENORRHEA; ANALGESIA; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG ADMINISTRATION ROUTE; DRUG SELF ADMINISTRATION; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HOME; HUMAN; NAUSEA AND VOMITING; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH;

EID: 27644535840     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.02.019     Document Type: Article

References (16)

1. M. Bygdeman, K. Gemzell-Danielsson, and L. Marions Medical termination of early pregnancy: the Swedish experience JAMWA 55 2000 195 196
2. D.R. Urquhart, A.A. Templeton, F. Shinewi, M. Chapman, K. Hawkins, and J. McGarry The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK multicenter study - final results Contraception 55 1997 1 5
3. G. Watkinson, A. Hopkins, and F.A. Akbar The therapeutic efficacy of misoprostol in peptic ulcer disease Postgrad Med J 64 Suppl. 1 1988 60 77
4. I.M. Spitz, C.W. Bardin, L. Benton, and A. Robbins Early pregnancy termination with mifepristone and misoprostol in the United States N Engl J Med 338 1998 1241 1247
5. M. Bygdeman, and K. Gemzell-Danielsson Options for early therapeutic abortion Drugs 62 15 2002 1 12
6. E. Pirrucello Newhall, and B. Winikoff Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions Am J Obstet Gynecol 183 2000 44 53
7. C. McKinley, K.J. Thong, and D.T. Baird The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol Hum Reprod 8 1993 1502 1505
8. H. El-Refaey, D. Rajasekar, M. Abdalla, L. Calder, and A. Templeton Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol N Engl J Med 332 1995 983 987
9. H. von Hertzen, H. Honkanen, G. Piaggio, G. Bartfai, R. Erdenetungalag, and K. Gemzell-Danielsson WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy BJOG 110 2003 808 818
10. P.C. Ho, S.W. Ngai, K.L. Liu, G.C. Wong, and S.W. Lee Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy Obstet Gynecol 90 1997 735 738
11. B. Winikoff, C. Ellertson, B. Elul, and I. Sivin Acceptability and feasability of early pregnancy termination by mifepristone-misoprostol Arch Fam Med 7 1998 360 366
12. E.A. Schaff, S.L. Fielding, S.H. Eisinger, L.S. Stadalius, and L. Fuller Low-dose mifepristone followed by vaginal misoprostol at 48 h for abortion up to 63 days Contraception 61 2000 41 46
13. M.P. Jensen, L. Miller, and L.D. Fischer Assessment of pain during medical procedures: a comparison of three scales Clin J Pain 4 1998 343 349
14. E. Wiebe Pain control in medical abortion Int J Gynecol Obstet 74 2001 275 280
15. B. Kruse, S. Poppema, M.D. Creinin, and M. Paul Management of side effects and complications in medical abortion Am J Obstet Gynecol 183 2000 65 75
16. S.W. Ngai, O.S. Tang, and P.C. Ho Randomized comparison of vaginal (200 μg every 3 h) and oral (400 μg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy Hum Reprod 15 2000 2205 2208